We know that understanding your assay is critical to creating a successful microfluidic point-of-care device, but that's just the beginning.  Adaptation of biochemical processes to a microfluidic format is not a straightforward or predictable process of just scaling down each assay step. It is a complex endeavour interfacing biochemistry with micro-engineering, manufacturing automation, supply-chain logistics, regulatory constraints, commercial concerns and more.

Our in-house bioscience capability is dedicated to solving these complex problems in order to translate your science into real world products destined for commercial success.

Our  dedicated team of scientists provide technical expertise and guidance on the adaptation and transfer of biological assays and systems onto microfluidic platforms through understanding the impact of the micro-engineered environment on each biological assay step.

Our team has expertise in assay development and translation across molecular, cellular and immunological applications including PCR, ELISA, antibody conjugation, cell cultures, reagent spotting and fluorescence microscopy. This team works closely with engineers and stakeholders throughout product development process guiding assay translation activities such as sample preparation, assay reaction(s) between sample and reagents, and analyte detection.